Trials / Completed
CompletedNCT01373398
Safety and Pharmacokinetic Study of EO9(Intravesical Instillation)
Phase I Clinical Trial to Evaluate the Safety and Pharmacokinetics of Intravesical Instillation of EO9 in Patients With Non-muscle Invasive Bladder Cancer(NMIBC)
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Handok Inc. · Industry
- Sex
- All
- Age
- 20 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and pharmacokinetics (PK) of intravesical instillation of EO9 in patients with non-muscle invasive bladder cancer (NMIBC).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | EO9(Apaziquone) | immediate instillation after TURBT + 6 weekly instillation 4mg/mL Apaziquone |
Timeline
- Start date
- 2011-05-01
- Primary completion
- 2012-02-01
- First posted
- 2011-06-15
- Last updated
- 2012-03-13
Locations
2 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01373398. Inclusion in this directory is not an endorsement.